BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18472015)

  • 1. P53, cyclin-dependent kinase and abnormal amplification of centrosomes.
    Fukasawa K
    Biochim Biophys Acta; 2008 Sep; 1786(1):15-23. PubMed ID: 18472015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells.
    Hanashiro K; Kanai M; Geng Y; Sicinski P; Fukasawa K
    Oncogene; 2008 Sep; 27(40):5288-302. PubMed ID: 18490919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression.
    Mussman JG; Horn HF; Carroll PE; Okuda M; Tarapore P; Donehower LA; Fukasawa K
    Oncogene; 2000 Mar; 19(13):1635-46. PubMed ID: 10763820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway.
    Tarapore P; Horn HF; Tokuyama Y; Fukasawa K
    Oncogene; 2001 May; 20(25):3173-84. PubMed ID: 11423967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase control of centrosome duplication.
    Lacey KR; Jackson PK; Stearns T
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2817-22. PubMed ID: 10077594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression.
    Kawamura K; Izumi H; Ma Z; Ikeda R; Moriyama M; Tanaka T; Nojima T; Levin LS; Fujikawa-Yamamoto K; Suzuki K; Fukasawa K
    Cancer Res; 2004 Jul; 64(14):4800-9. PubMed ID: 15256449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrosome amplification, chromosome instability and cancer development.
    Fukasawa K
    Cancer Lett; 2005 Dec; 230(1):6-19. PubMed ID: 16253756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability.
    Cheng X; Shen Z; Yang J; Lu SH; Cui Y
    J Biol Chem; 2008 Feb; 283(9):5888-98. PubMed ID: 18162463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenes and tumour suppressors take on centrosomes.
    Fukasawa K
    Nat Rev Cancer; 2007 Dec; 7(12):911-24. PubMed ID: 18004399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in the centrosome duplication regulatory activity among p53 'hot spot' mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53.
    Tarapore P; Tokuyama Y; Horn HF; Fukasawa K
    Oncogene; 2001 Oct; 20(47):6851-63. PubMed ID: 11687964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication.
    Shinmura K; Bennett RA; Tarapore P; Fukasawa K
    Oncogene; 2007 May; 26(20):2939-44. PubMed ID: 17072342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle: driving the centrosome cycle.
    Winey M
    Curr Biol; 1999 Jun; 9(12):R449-52. PubMed ID: 10375518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrosome aberrations and cancer.
    Krämer A; Ho AD
    Onkologie; 2001 Dec; 24(6):538-44. PubMed ID: 11799308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal centrosome amplification in the absence of p53.
    Fukasawa K; Choi T; Kuriyama R; Rulong S; Vande Woude GF
    Science; 1996 Mar; 271(5256):1744-7. PubMed ID: 8596939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-Driven apoptosis limits centrosome amplification and genomic instability downstream of NPM1 phosphorylation.
    Cuomo ME; Knebel A; Morrice N; Paterson H; Cohen P; Mittnacht S
    Nat Cell Biol; 2008 Jun; 10(6):723-30. PubMed ID: 18454140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells.
    Adon AM; Zeng X; Harrison MK; Sannem S; Kiyokawa H; Kaldis P; Saavedra HI
    Mol Cell Biol; 2010 Feb; 30(3):694-710. PubMed ID: 19933848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication.
    Tokuyama Y; Horn HF; Kawamura K; Tarapore P; Fukasawa K
    J Biol Chem; 2001 Jun; 276(24):21529-37. PubMed ID: 11278991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centrosome-targeting region of CG-NAP causes centrosome amplification by recruiting cyclin E-cdk2 complex.
    Nishimura T; Takahashi M; Kim HS; Mukai H; Ono Y
    Genes Cells; 2005 Jan; 10(1):75-86. PubMed ID: 15670215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The centrosome in normal and transformed cells.
    Wang Q; Hirohashi Y; Furuuchi K; Zhao H; Liu Q; Zhang H; Murali R; Berezov A; Du X; Li B; Greene MI
    DNA Cell Biol; 2004 Aug; 23(8):475-89. PubMed ID: 15307950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial genome regulates mitotic fidelity by maintaining centrosomal homeostasis.
    Donthamsetty S; Brahmbhatt M; Pannu V; Rida PC; Ramarathinam S; Ogden A; Cheng A; Singh KK; Aneja R
    Cell Cycle; 2014; 13(13):2056-63. PubMed ID: 24799670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.